SCHEMBL19260951

SCHEMBL19260951

CC(C)(C)OC(=O)N1CCN(c2cc(Cl)ccc2C=O)CC1

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.52
KMT2A Q03164 5/20 0.52
STS P08842 3/20 0.48
MAPT P10636 3/20 0.48
HTT P42858 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
POLB P06746 1/20 0.46
ALDH1A1 P00352 2/20 0.45
LMNA P02545 2/20 0.45
IDE P14735 2/20 0.45
CYP3A4 P08684 1/20 0.44
CYP3A5 P20815 1/20 0.44
MAP4K4 O95819 1/20 0.44
SMARCA2 P51531 1/20 0.43
SMARCA4 P51532 1/20 0.43
PBRM1 Q86U86 1/20 0.43
MAPK1 P28482 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29417701 1.00 MEN1 (0.52) MEN1KMT2ASTSMAPTHTT
SCHEMBL24187329 0.95 MEN1 (0.57) MEN1KMT2ASTSMAPTHTT
SCHEMBL30396987 0.95 MEN1 (0.57) MEN1KMT2ASTSMAPTHTT
SCHEMBL31618903 0.90 MEN1 (0.52) MEN1KMT2ASTSMAPTHTT
SCHEMBL2421324 0.90 MEN1 (0.52) MEN1KMT2ASTSMAPTHTT
SCHEMBL20769635 0.88 CYP11B2 (0.47) MEN1KMT2ASTSMAPTPOLB
SCHEMBL18064880 0.86 USP30 (0.45) MEN1KMT2ASTSMAPT
SCHEMBL31618908 0.85 MAPT (0.45) MEN1KMT2AMAPTSMN1; SMN2POLB
SCHEMBL24187486 0.85 BACE1 (0.51) MEN1KMT2AMAPTPOLBALDH1A1
SCHEMBL24187293 0.85 MAPT (0.45) MEN1KMT2AMAPTSMN1; SMN2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115720578-A Tricyclic derivative, preparation method and medical application thereof 深圳信立泰药业股份有限公司 2023-02-28 CN disclosed
CN-109496213-B Spiro compounds and methods of making and using the same H.隆德贝克有限公司 2022-03-04 CN disclosed
WO-2022007866-A1 FUSED TRICYCLIC DERIVATIVE, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL APPLICATION THEREOF 深圳信立泰药业股份有限公司 2022-01-13 WO disclosed
EP-3455226-B1 SPIROCYCLE COMPOUNDS AND METHODS OF MAKING AND USING SAME LUNDBECK LA JOLLA RESEARCH CENTER INC (US) 2020-12-30 EP disclosed
EP-3455226-B1 SPIROCYCLE COMPOUNDS AND METHODS OF MAKING AND USING SAME LUNDBECK LA JOLLA RESEARCH CENTER INC (US) 2020-12-30 EP disclosed
US-10781211-B2 Spirocycle compounds and methods of making and using same LUNDBECK LA JOLLA RESEARCH CENTER, INC. (US) 2020-09-22 US disclosed
US-10781211-B2 Spirocycle compounds and methods of making and using same LUNDBECK LA JOLLA RESEARCH CENTER, INC. (US) 2020-09-22 US disclosed
US-10463753-B2 Radiolabeled monoacylglycerol lipase occupancy probe LUNDBECK LA JOLLA RESEARCH CENTER, INC. (US) 2019-11-05 US disclosed
US-10463753-B2 Radiolabeled monoacylglycerol lipase occupancy probe LUNDBECK LA JOLLA RESEARCH CENTER, INC. (US) 2019-11-05 US disclosed
EP-3455226-A1 SPIROCYCLE COMPOUNDS AND METHODS OF MAKING AND USING SAME Abide Therapeutics, Inc. (US) 2019-03-20 EP disclosed
US-10030020-B2 Spirocycle compounds and methods of making and using same ABIDE THERAPEUTICS, INC. (US) 2018-07-24 US disclosed
US-10030020-B2 Spirocycle compounds and methods of making and using same ABIDE THERAPEUTICS, INC. (US) 2018-07-24 US disclosed
US-10030020-B2 Spirocycle compounds and methods of making and using same ABIDE THERAPEUTICS, INC. (US) 2018-07-24 US disclosed
WO-2017197192-A1 SPIROCYCLE COMPOUNDS AND METHODS OF MAKING AND USING SAME ABIDE THERAPEUTICS, INC. (US) 2017-11-16 WO disclosed
WO-2017197192-A1 SPIROCYCLE COMPOUNDS AND METHODS OF MAKING AND USING SAME ABIDE THERAPEUTICS, INC. (US) 2017-11-16 WO disclosed
US-20170327500-A1 SPIROCYCLE COMPOUNDS AND METHODS OF MAKING AND USING SAME H. LUNDBECK A/S (DK) 2017-11-16 US disclosed
US-20170327500-A1 SPIROCYCLE COMPOUNDS AND METHODS OF MAKING AND USING SAME H. LUNDBECK A/S (DK) 2017-11-16 US disclosed
US-20170327500-A1 SPIROCYCLE COMPOUNDS AND METHODS OF MAKING AND USING SAME H. LUNDBECK A/S (DK) 2017-11-16 US disclosed
WO-2017143283-A1 RADIOLABELED MONOACYLGLYCEROL LIPASE OCCUPANCY PROBE ABIDE THERAPEUTICS, INC. (US) 2017-08-24 WO disclosed
WO-2017143283-A1 RADIOLABELED MONOACYLGLYCEROL LIPASE OCCUPANCY PROBE ABIDE THERAPEUTICS, INC. (US) 2017-08-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10781211-B2 Spirocycle compounds and methods of making and using same ABHD6, ABHD16A, ACSL6 MEN1 3674/4885KMT2A 3691/4885STS 1467/4885
US-10463753-B2 Radiolabeled monoacylglycerol lipase occupancy probe MGLL, LPL, PNLIP MEN1 1005/4885KMT2A 1647/4885STS 592/4885
US-20170327500-A1 SPIROCYCLE COMPOUNDS AND METHODS OF MAKING AND USING SAME ABHD6, ABHD16A, ACSL6 MEN1 3674/4885KMT2A 3691/4885STS 1467/4885
US-10030020-B2 Spirocycle compounds and methods of making and using same ABHD6, ABHD16A, ACSL6 MEN1 3674/4885KMT2A 3691/4885STS 1467/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.